Astrazeneca-Oxford Vaccine Approved for Use in the U.K
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Old Road Campus
Old Road Campus 4a, 4b, 4c, U5 n o t Oxford City Centre g OLD ROAD n i d 4a, 4b, 4c, U5 a e H K O L L A D R O W AD E M I L 4,4a,4b,4c, U1X,U5 A41 42 4,4a,4b,4c,U5 Rin D 4 g R oad 6 7 1 13 3 11 C H U R C H I L L 900 D 2 R I 700, 900 V E E O x f o 5 A C rd 12 C i ty 10 C e n t re B 8 CAR PARK C 9 h u r c R F h i O l l O S H E o V s N E p L i T t DRI a VE ENTRANCE ROOSEVELT DRIVE l 900, ST2 Index 1 The Triangle Nursery 9 Old Road Campus Estates Annexe 13 Boundary Brook House Interserve Joint Research Office Kennedy Institute 2 - Research Services, Medical Sciences Division Old Road Campus Research Building 10 - Clinical Trials and Research Governance 3 New Richards Building Department of Oncology - Human Tissue Governance CRUK/MRC Oxford Institute for Radiation Oncology - Medical Sciences Division Business Development 4 NDM Research Building Institute of Biomedical Engineering Nuffield Department of Primary Care Health Sciences Target Discovery Institute Jenner Institute Medical Sciences Divisional Safety Officers Centre for Tropical Medicine and Global Health Bodleian Knowledge Centre (Library Services) Medical Sciences Division IT Services 5 Wellcome Centre for Human Genetics (WHG) Ludwig Institute for Cancer Research Structural Genomics Consortium 6 Henry Wellcome Building for Molecular Physiology Nuffield Department of Surgical Sciences Loading Bays and Delivery Offices of the Nuffield Professor of Medicine ENTRANCE VIA BUILDING 5 11 Big Data Institute A Wellcome Trust Centre for Human Genetics 7 Henry Wellcome Building for Particle Imaging -
Conference Program Table of Contents Agenda 3 Conference Chairs 12 Moderators & Speakers 14 Our Partners 42 Exhibitors 44
AIMSE 2017 Fall Conference October 11–12 Princeton Club New York CONFERENCE PROGRAM TABLE OF CONTENTS AGENDA 3 CONFERENCE CHAIRS 12 MODERATORS & SPEAKERS 14 OUR PARTNERS 42 EXHIBITORS 44 As a participant in the CFA Institute Approved-Provider Program, AIMSE has determined that this program qualifies for 5 credit hours. If you are a CFA Institute member, credit for your participation in this program will automatically be recorded in your CE tracking tool. AGENDA OCTOBER 11, 2017 12:00 pm – 6:00 pm Registration 1:15 – 1:30 pm Welcome Remarks James Madison Room CONFERENCE CO-CHAIRS Tim Hill Vice President, Sales & Marketing Q- Emerging Markets Corp. Michael Gillis Senior Vice President, Business Development Greystone Managed Investments, Inc. AIMSE PRESIDENT Carolyn Patton, CFA Head of Distribution Americas First State Investments 1:30 – 2:10 pm What’s Going On? James Madison Room To kick off the conference we will hear from leading industry thinkers about the state of the industry today and where it is headed tomorrow. What are investors thinking given the ever-changing global investment landscape and how will that lead to changes in portfolio allocations? MODERATOR Bart Marchant Institutional Regional Director, Southeast WisdomTree Asset Management SPEAKERS Safia Mehta, CFA Senior Vice President, Portfolio Manager Progress Investment Management Company, LLC Timothy Ng Chief Investment Officer Clearbrook Timothy Taylor Senior Investment Officer, Global Equity Florida State Board of Administration Mark Yusko Chief Executive Officer & Chief Investment Officer Morgan Creek Capital Management 3 2:15 – 3:10 pm New York State of Mind James Madison Room With over a trillion dollars of investable assets in pension plans, endowments, foundations and family offices, the State of New York is home to one of the largest pools of capital available to investment managers. -
Unisys Company Overview Disclaimer
Unisys Company Overview Disclaimer • This presentation includes certain financial measures not presented in accordance with U.S. generally accepted accounting principles (“GAAP”), including, but not limited to, EBITDA, Adjusted EBITDA, Free Cash Flow, Adjusted Free Cash Flow, and constant currency, and certain ratios and other metrics derived therefrom. These non-GAAP financial measures are not measures of financial performance in accordance with GAAP and may exclude items that are significant in understanding and assessing the Company’s financial results. • Therefore, these measures should not be considered in isolation or as an alternative to cash flows from operations or other measures of profitability, liquidity or performance under GAAP. You should be aware that the Company’s presentation of these measures may not be comparable to similarly-titled measures used by other companies. Reconciliations of all non-GAAP financial measures are available in this presentation. © 2016 Unisys Corporation. All rights reserved. 2 Unisys at a Glance >1,500 >20,000 130+ $3.0B Global clients Associates Countries 2015 globally served revenue >60 million air cargo 300 government transactions per agencies worldwide month More than 90 of the Fortune Global 500 companies Over half of the top 25 global banks and 18 of the top 25 Building one of the 10 of the world’s global airlines largest cloud-based, on top insurance demand U.S. state companies government computing environments © 2016 Unisys Corporation | All rights reserved. 3 Key Company Highlights 1 Diversified Revenue Model 2 Long-Standing Relationships with Blue-chip Client Base 3 Leading-Edge Technological Solutions 4 Recurring Service Revenue with Large Contractual Backlog 5 Financial Progress 6 Experienced Management Team © 2016 Unisys Corporation. -
In the United States District Court for the District Of
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FOREST LABORATORIES, LLC and ) FOREST LABORATORIES ) HOLDINGS, LTD., ) ) Plaintiffs, ) ) v. ) Civ.No.14-1119-SLR ) SIGMAPHARM LABORATORIES, LLC, ) et al., ) ) Defendants. ) Jack B. Blumenfeld, Esquire and Maryellen Noreika, Esquire of Morris, Nichols, Arsht & Tunnell LLP, Wilmington, Delaware. Counsel for Plaintiffs. Of Counsel: Howard W. Levine, Esquire, Sanya Sukduang, Esquire, Jonathan R. Davies, Esquire, Courtney B. Gasp, Esquire, and Charles E. Lipsey, Esquire of Finnegan, Henderson, Farabow, Garrett & Dunner LLP. John C. Phillips, Esquire, David A. Bilson, Esquire and Megan C. Haney of Phillips, Goldman, Mclaughlin & Hall, P.A., Wilmington, Delaware. Counsel for Defendant Sigmapharm Laboratories, LLC. Of Counsel: Anthony G. Simon, Esquire, Anthony R. Friedman, Esquire, Benjamin R. Askew, Esquire, and Michael P. Kella, Esquire of The Simon Law Firm, P.C. Karen Elizabeth Keller, Esquire and Jeffrey Thomas Castellano, Esquire of Shaw Keller, LLP, Wilmington, Delaware. Counsel for Defendants Hikma Pharmaceuticals LLC, Hikma Pharmaceuticals PLC, and West-Ward Pharmaceutical Corp. Of Counsel: lmron T. Aly, Esquire, Joel M. Wallace, Esquire, and Helen H. Ji, Esquire of Schiff Hardin LLP. Richard D. Kirk, Esquire, Stephen B. Brauerman, Esquire and Sara E. Bussiere, Esquire of Bayard, P.A., Wilmington, Delaware. Counsel for Defendant Breckenridge Pharmaceutical, Inc. Of Counsel: Beth D. Jacob, Esquire, Clifford Katz, Esquire, and Malavika A. Rao, Esquire of Kelley, Drye & Warren LLP. Karen Pascale, Esquire and Pilar G. Kraman, Esquire of Young, Conaway, Stargatt & Taylor, LLP, Wilmington, Delaware. Counsel for Defendants Alembic Pharmaceuticals Ltd., Alembic Global Holding SA and Alembic Pharmaceuticals, Inc. Of Counsel: Steven J. Lee, Esquire, Michael K. -
Preclinical Development & IND Filing: Nuts, Bolts, Best Practices
“Preclinical Development & IND Filing: Nuts, Bolts, Best Practices and Regulatory Aspects.” Speakers: Amit Kalgutkar (Pfizer), Chandra Prakash (Agios), Sanjeev Thohan (Novartis), Li- Chun Wang (Takeda), Wei Yin (Biogen) Organizers: Sanjeev Thohan and Chandra Prakash Date: 6/29/2017 Time: 8:30 am – 5.00 pm Location: Boston/Cambridge Area: Marriott Kendall Square, 50 Broadway, Cambridge MA 02142 Fees: $175 - Regular (before June 1st, 2017), $225 - Regular (after June 1st, 2017); $125 - Unemployed & Academic; $2000 - Major Sponsorship; $475 - Vendor Show Registration: www.PBSS.org Workshop Description: An investigational new drug application (IND) is an important milestone that marks the entry of a molecule into clinical development. Knowing the objectives, expectations and processes of assembling an IND is a key to not only successful filing, but also a promising clinical development path forward. Often there are cases where too many of our “nice-to-have” studies crowd the package at the expense of critical study needs/issues. This can lead to significant delays in clinical developments with back-and-forth of Q&A sessions both internally and with regulatory agencies. As we have seen, the regulatory landscape is changing as rapidly as the industry innovates into new therapeutic modalities. Therefore, it is critical to keep up to date on regulatory requirements and the industry’s best practices in different aspects of the IND: non- clinical safety, PK, CMC, and clinical plans. In this workshop, our speakers who bring years of experience with multiple successful IND filings, will discuss systematically the preclinical studies required for small molecule IND’s as well as the nuts and bolts of putting together a high–quality IND package. -
Assessment Report COVID-19 Vaccine Astrazeneca EMA/94907/2021
29 January 2021 EMA/94907/2021 Committee for Medicinal Products for Human Use (CHMP) Assessment report COVID-19 Vaccine AstraZeneca Common name: COVID-19 Vaccine (ChAdOx1-S [recombinant]) Procedure No. EMEA/H/C/005675/0000 Note Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted. Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 An agency of the European Union © European Medicines Agency, 2021. Reproduction is authorised provided the source is acknowledged. Table of contents 1. Background information on the procedure .............................................. 7 1.1. Submission of the dossier ..................................................................................... 7 1.2. Steps taken for the assessment of the product ........................................................ 9 2. Scientific discussion .............................................................................. 12 2.1. Problem statement ............................................................................................. 12 2.1.1. Disease or condition ........................................................................................ 12 2.1.2. Epidemiology and risk factors ........................................................................... 12 2.1.3. Aetiology and pathogenesis ............................................................................. -
Cynthia Kyriazis Is a Productivity Strategist, Organization Consultant, Time Management Coach, Speaker, and Author
Cynthia Kyriazis is a productivity strategist, organization consultant, time management coach, speaker, and author. She leads decision-makers, their teams, and staff in navigating the 24/7 demands on their time and energy by developing a clear line of sight on what’s important and a plan for how to get there. 80% of Cynthia’s clients report saving at least 45 minutes a day in real time and 91% have improved their overall productivity. Cynthia possesses a 20-year track record of success in serving Fortune 500 companies, entrepreneurial businesses, government, and non-profit agencies. Regardless of the organization size, Cynthia guides leaders and Cynthia star performers to make choices that create and sustain a productive kyriazis mindset, and positively impact both personal growth and organizational profitability. Cynthia is the Amazon best-selling author of Get Organized. Get Focused. Get Productivity Moving. How to Overcome Productivity Potholes. She has also been featured & Organization as an expert on Forbes.com, Wall Street Journal online, the Philadelphia Consultant Inquirer, Legal Intelligencer, and many regional publications, radio, and television shows – and was named one of the “28 Best Online Productivity Experts” by New York Times best-selling author Hank Reardon in his book Time Management 2.0. Organizations Qualifications & Education We Have Served • Past-Secretary to the National Association of Professional Organizers (NAPO) • American Diabetes Association • Past-President of the Kansas City chapter of the International Society for • Avery Dennison Performance Improvement (KC-ISPI) • Bayer HealthCare • Consultant to the American Coaching Association • Campbell Soup Company • Certified Professional Behavioral Analyst (CPBA) • Cerner • Certified Professional Values Analyst (CPVA) • Cisco • B.S., Communication, University of Kansas • Coca Cola Bottling • Eli Lily Endorsements • GlaxoSmithKline • G.E. -
Annual Meeting
Volume 97 | Number 5 Volume VOLUME 97 NOVEMBER 2017 NUMBER 5 SUPPLEMENT SIXTY-SIXTH ANNUAL MEETING November 5–9, 2017 The Baltimore Convention Center | Baltimore, Maryland USA The American Journal of Tropical Medicine and Hygiene The American Journal of Tropical astmh.org ajtmh.org #TropMed17 Supplement to The American Journal of Tropical Medicine and Hygiene ASTMH FP Cover 17.indd 1-3 10/11/17 1:48 PM Welcome to TropMed17, our yearly assembly for stimulating research, clinical advances, special lectures, guests and bonus events. Our keynote speaker this year is Dr. Paul Farmer, Co-founder and Chief Strategist of Partners In Health (PIH). In addition, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, will deliver a plenary session Thursday, November 9. Other highlighted speakers include Dr. Scott O’Neill, who will deliver the Fred L. Soper Lecture; Dr. Claudio F. Lanata, the Vincenzo Marcolongo Memorial Lecture; and Dr. Jane Cardosa, the Commemorative Fund Lecture. We are pleased to announce that this year’s offerings extend beyond communicating top-rated science to direct service to the global community and a number of novel events: • Get a Shot. Give a Shot.® Through Walgreens’ Get a Shot. Give a Shot.® campaign, you can not only receive your free flu shot, but also provide a lifesaving vaccine to a child in need via the UN Foundation’s Shot@Life campaign. • Under the Net. Walk in the shoes of a young girl living in a refugee camp through the virtual reality experience presented by UN Foundation’s Nothing But Nets campaign. -
03.031 Socc04 Final 2(R)
STATEOF CENTER CITY 2008 Prepared by Center City District & Central Philadelphia Development Corporation May 2008 STATEOF CENTER CITY 2008 Center City District & Central Philadelphia Development Corporation 660 Chestnut Street Philadelphia PA, 19106 215.440.5500 www.CenterCityPhila.org TABLEOFCONTENTSCONTENTS INTRODUCTION 1 OFFICE MARKET 2 HEALTHCARE & EDUCATION 6 HOSPITALITY & TOURISM 10 ARTS & CULTURE 14 RETAIL MARKET 18 EMPLOYMENT 22 TRANSPORTATION & ACCESS 28 RESIDENTIAL MARKET 32 PARKS & RECREATION 36 CENTER CITY DISTRICT PERFORMANCE 38 CENTER CITY DEVELOPMENTS 44 ACKNOWLEDGEMENTS 48 Center City District & Central Philadelphia Development Corporation www.CenterCityPhila.org INTRODUCTION CENTER CITY PHILADELPHIA 2007 was a year of positive change in Center City. Even with the new Comcast Tower topping out at 975 feet, overall office occupancy still climbed to 89%, as the expansion of existing firms and several new arrivals downtown pushed Class A rents up 14%. For the first time in 15 years, Center City increased its share of regional office space. Healthcare and educational institutions continued to attract students, patients and research dollars to downtown, while elementary schools experienced strong demand from the growing number of families in Center City with children. The Pennsylvania Convention Center expansion commenced and plans advanced for new hotels, as occupancy and room rates steadily climbed. On Independence Mall, the National Museum of American Jewish History started construction, while the Barnes Foundation retained designers for a new home on the Benjamin Franklin Parkway. Housing prices remained strong, rents steadily climbed and rental vacancy rates dropped to 4.6%, as new residents continued to flock to Center City. While the average condo sold for $428,596, 115 units sold in 2007 for more than $1 million, double the number in 2006. -
Jenner Institute Complementary Vaccines Platform Technologies
WHO R&D Blueprint: Janssen Vaccines – Jenner Institute complementary Vaccines Platform Technologies Janssen Vaccines: Jenner Institute: Olga Popova Prof. Sarah Gilbert Jerome Custers WHO Geneva, 21 July 2016 Background • Jenner Institute & Janssen Vaccines presented respective proposals to WHO R&D Blueprint Workshop in April 2016, and were invited to join forces for Round 2 submission • Example of alignment, coordination and partnership between public and private sector stakeholders • Understanding nature of vaccine development, established complementary end‐to‐end skills and capabilities • Long‐term, sustainable & consistent approach and funding • High‐level flexible proposal with illustrative examples • «Bona fide»: collaborative framework to be developed JOINTLY TOWARDS TANGIBLE OUTCOMES x GLOBAL PUBLIC HEALTH 2 Success factors • Available platforms and previous experience with pathogens • Ability to invest time and resources, leverage expertise, minimise opportunity costs and ensure business continuity • Appropriate and functionable operational model, speed • Lean governance, partner alignment and milestone orientation INTERNAL • Reliable & qualified partners, durable commitments • Long‐term reliable funding (min 5‐year horizon) • Resolving vaccination indemnification / liability issue • Consistency in pathogen prioritisation and defined, consistent pre‐ established endpoint commitment • Clear and accelerated / streamlined regulatory pathways, conditions & predictability of licensure EXTERNAL • Anticipated deployment plans and community -
Local Producers Sparkling Pinot Grigio & Sauvignon Blanc Riesling
Wine List Local Producers 1 & 2 Sparkling 3 Pinot Grigio & Sauvignon Blanc 4 Riesling & Unique White Varietals 5 Chardonnay 6 Rose' 7 Pinot Noir & Spanish Reds 8 Italian Reds by Region 9 & 10 Merlot & Malbec 11 Red Blends by Region 12 & 13 Cabernet Sauvignon 14 Syrah/Shiraz & Zinfandel 15 Local Producers White Bellview Winery Traminette Landisville, NJ 8 30 Sharott Winery Vidal Blanc Hammonton, NJ 8 30 Sharott Winery Vignoles Hammonton, NJ 8 30 Amalthea's "Green Dragon" Chardonnay A tco, NJ 9 34 RED Amalthea Cellars Pinot Noir Hammonton, NJ 9 34 DiMatteo Vineyard "Pasquale Red" Hammonton, NJ 8 30 C oncord & Ives Plagido's Winery " Concetta's Casalinga" Hammonton, NJ 8 30 F ield B lend Bellview Winery Coeur D'Est Landisville, NJ 11 42 C ab ern et F ran c , C h am b o u rc in , M erlo t, & P etit V erd o t Valenzano Winery Malbec Shamong, NJ 10 38 Bellview Winery Cabernet Franc Landisville, NJ 11 42 Amalthea Cellars Legends Europa III A tco , NJ 11 42 C abernet Sauvignon, C abernet Franc, & M erlot Valenzano Winery Port Shamong, NJ 8 30 1 Local Producers Fruit (non-grape) DiMatteo Vineyard Blueberry Hammonton, NJ 8 30 Tomasello Winery Cranberry Hammonton, NJ 8 30 Tomasello Winery Cherry Hammonton, NJ 8 30 Tomasello Winery Pomegranate Hammonton, NJ 8 30 Tomasello Winery Sparkling Blueberry Hammonton, NJ 8 30 2 Sparkling Juame Serra Cristalino Brut Cava Penedes, Spai n NV 8 30 Tomasello Winery Sparkling Blueberry Hammonton, NJ NV 8 30 Lobetia Pink Bubbles L a M ancha, Spai n NV 8 30 O rganic, G arnacha & B obal House Prosecco V eneto, I tal y NV 9 34 Braida Moscato D'Asti Vigna S.N. -
Totally Blank Broadsheet
A8 • Adirondack Daily Enterprise • adirondackdailyenterprise.com • Wednesday, June 17, 2020 Want to see your sports news and photos in the Enterprise? Contact the sports department at 891-2600 ext. 26 Sports or [email protected] 19 students earn black belts as local school closes By LOU REUTER Senior Sports Writer SARANAC LAKE — Grand Master Jon O’Kelly’s final day of being a Taekwondo instructor was one of his most memorable ones. After a 35-year career of teaching the martial art, O’Kelly has retired. A Saranac Lake resident, O’Kelly opened the Northeast Taekwondo school in this village in Sept. 2016. On Saturday, he performed his final duty as the head of the school, pro - moting 19 local students to black belts during an outdoor ceremony held on the North Country Commu - nity College soccer field. O’Kelly said all 19 who were promoted were original students of the Saranac Lake-based school when it opened nearly four years ago, and the youngest new black belt earner was 9-year-old Cole Davide. The ceremony was held on a chilly, damp day with plenty of space between the students, who all wore matching black facemasks that included an image of a martial artist. The day began with testing and ended with the handing out of black belts and certificates. O’Kelly said Easton Crary is presented his black belt by Northeast Taek - he was especially impressed with wondo school instructor Grand Master Jon O’Kelly. the display by his students because the school has been shut down for itself.” he said.